HomeAPVO • NASDAQ
add
Aptevo Therapeutics Inc
Previous close
$3.88
Day range
$3.97 - $4.63
Year range
$3.84 - $1,299.60
Market cap
5.05M USD
Avg Volume
65.56K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.00M | -6.05% |
Net income | -5.81M | 8.02% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.92M | 6.27% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.62M | 148.10% |
Total assets | 27.19M | 74.42% |
Total liabilities | 9.81M | -9.44% |
Total equity | 17.38M | — |
Shares outstanding | 1.18M | — |
Price to book | 0.22 | — |
Return on assets | -55.32% | — |
Return on capital | -67.84% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -5.81M | 8.02% |
Cash from operations | -5.24M | 9.08% |
Cash from investing | — | — |
Cash from financing | 5.79M | -13.78% |
Net change in cash | 558.00K | -41.94% |
Free cash flow | -3.17M | 7.32% |
About
Founded
2016
Headquarters
Website
Employees
37
